These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8762533)

  • 1. [Adherent mechanism of the mutans of Actinomyces viscosus T14V].
    Guan W; Liu Z
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1995 Nov; 30(6):329-31, 383. PubMed ID: 8762533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study on biological properties of fimbriae of A. viscosus. III. Adherence activity of fimbriae of A. viscosus].
    Liu T; Li W; Yue S
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 May; 17(2):169-72. PubMed ID: 12539718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutants of Actinomyces viscosus T14V lacking type 1, type 2, or both types of fimbriae.
    Cisar JO; Vatter AE; Clark WB; Curl SH; Hurst-Calderone S; Sandberg AL
    Infect Immun; 1988 Nov; 56(11):2984-9. PubMed ID: 2902012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Binding of Actinomyces viscosus to collagen].
    Liu TJ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 Jul; 27(4):212-4, 256. PubMed ID: 1303830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The study of actinomyces viscosus adhere to teeth. IV. The study of salivary protein receptors of A. viscosus].
    Zhao L; Liu T; Yue S
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 Feb; 15(1):58-60. PubMed ID: 11480063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of adherence of Actinomyces naeslundii (Actinomyces viscosus) T14V-J1 to saliva-treated hydroxyapatite by a monoclonal antibody to type 1 fimbriae.
    Nesbitt WE; Beem JE; Leung KP; Stroup S; Swift R; McArthur WP; Clark WB
    Oral Microbiol Immunol; 1996 Feb; 11(1):51-8. PubMed ID: 8604255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral bacterial attachment to titanium surfaces: a scanning electron microscopy study.
    Wu-Yuan CD; Eganhouse KJ; Keller JC; Walters KS
    J Oral Implantol; 1995; 21(3):207-13. PubMed ID: 8699514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study on biological properties of fimbriae of Actinomyces viscosus. II. Chemical characteristics of fimbriae of A. viscosus].
    Li W; Liu T; Zhang C; Yue S; Zhao C
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 May; 17(2):166-8. PubMed ID: 12539717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fimbriae of Actinomyces viscosus t14v: their relationship to the virulence-associated antigen and to coaggregation with Streptococcus sanguis 34.
    Cisar JO; McIntire FC; Vatter AE
    Adv Exp Med Biol; 1978; 107():695-701. PubMed ID: 84522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of fructans on dental biofilm formation by Streptococcus sobrinus, Streptococcus mutans, Streptococcus gordonii and Actinomyces viscosus.
    Rozen R; Bachrach G; Bronshteyn M; Gedalia I; Steinberg D
    FEMS Microbiol Lett; 2001 Feb; 195(2):205-10. PubMed ID: 11179653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro binding interactions of oral bacteria with immobilized fructosyltransferase.
    Shemesh M; Steinberg D
    J Appl Microbiol; 2006 Apr; 100(4):871-7. PubMed ID: 16553744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of bacterial interactions in the colonization of oral surfaces of Actinomyces viscosus.
    Kuramitsu HK; Paul A
    Infect Immun; 1980 Jul; 29(1):83-90. PubMed ID: 6772577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of bacterial adhesion in the oral cavity.
    Mergenhagen SE; Sandberg AL; Chassy BM; Brennan MJ; Yeung MK; Donkersloot JA; Cisar JO
    Rev Infect Dis; 1987; 9 Suppl 5():S467-74. PubMed ID: 2891180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A factor from Actinomyces viscosus T14V that specifically aggregates Streptococcus sanguis H1.
    Mizuno J; Cisar JO; Vatter AE; Fennessey PV; McIntire FC
    Infect Immun; 1983 Jun; 40(3):1204-13. PubMed ID: 6303957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against the Ag2 fimbriae of Actinomyces viscosus T14V inhibit lactose-sensitive bacterial adherence.
    Revis GJ; Vatter AE; Crowle AJ; Cisar JO
    Infect Immun; 1982 Jun; 36(3):1217-22. PubMed ID: 6124506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of in vitro attachment of Streptococcus sanguis and Actinomyces viscosus to saliva-treated titanium.
    Wolinsky LE; de Camargo PM; Erard JC; Newman MG
    Int J Oral Maxillofac Implants; 1989; 4(1):27-31. PubMed ID: 2599579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adhesion of actinomyces isolates to experimental pellicles.
    Steinberg D; Kopec LK; Bowen WH
    J Dent Res; 1993 Jun; 72(6):1015-20. PubMed ID: 8496474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of coaggregation between Actinomyces viscosus T14V and Streptococcus sanguis 34.
    McIntire FC; Vatter AE; Baros J; Arnold J
    Infect Immun; 1978 Sep; 21(3):978-88. PubMed ID: 30701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and function of Actinomyces naeslundii T14V type 1 fimbriae require the expression of additional fimbria-associated genes.
    Yeung MK; Ragsdale PA
    Infect Immun; 1997 Jul; 65(7):2629-39. PubMed ID: 9199430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific absence of type 2 fimbriae on a coaggregation-defective mutant of Actinomyces viscosus T14V.
    Cisar JO; Curl SH; Kolenbrander PE; Vatter AE
    Infect Immun; 1983 May; 40(2):759-65. PubMed ID: 6132880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.